FinTechFunding

Aro Biotherapeutics: Raises $88M in Series A Financing

  • Aro Biotherapeutics, a Philadelphia, PA-based biotechnology company pioneering the development of tissue-targeted genetic medicines, closed an $88m Series A financing
  • The round led by Northpond Ventures and Cowen Healthcare Investments, with participation from HealthCap, BVF Partners L.P., and Ridgeback Capital
  • The company also intends to use the funds to advance its lead therapeutic candidates into clinical development
  • Aro is developing a unique class of Centyrin-conjugated RNA therapies to efficiently and selectively target RNA medicines to the specific site of disease
  • Centyrins are small, stable, engineered human proteins with several properties that make them suited to target receptors on specific cells
  • Then the company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates
Previous article
Conotoxia: Launched MT4 platform
Next article
JPMorgan Chase: Acquires travel and loyalty business from cxLoyalty
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Mastercard Strengthens Payments Network with Agentic Transaction in Hong Kong

The innovative transaction marks a significant step in digital payments.Highlights: Mastercard successfully conducts an agentic transaction in Hong...
FinTech

OpenFX Raises $94M to Accelerate Growth in Fintech

The funding round aims to enhance OpenFX's innovative trading solutions.Highlights: OpenFX secures $94 million in funding.The investment will...
FinTech

Keyrock Strengthens Crypto Investment with $1.1 Billion Valuation

The crypto investment firm achieves a significant valuation milestone.Highlights: Keyrock hits a $1.1 billion valuation.Company focuses on crypto...
FinTech

Keyrock Strengthens Position with $1.1 Billion Valuation

Crypto investment specialist Keyrock secures significant market valuation boost.Highlights: Keyrock achieves a $1.1 billion valuation.Funding round aims to...